tom p wrote: ↑Fri Mar 19, 2021 9:19 am
I get your point, however there is a very good reason why there is zero chance of people outside ever being invited into these meetings to witness the discussions.
I wouldn't have expected that. I expected something more like the link you give below, except with some graphs or tables of data or something.
The past year has seen a lot of opening up of access, both in terms of real-time statistics on government websites, and in terms of preprints of scientific publications. Within the limits of industrial intellectual property protection and patient confidentiality I'd like to see the same from medicine regulators.
(The approval process seemed to go like "vaccine submitted to regulator and expected to be approved by [date]" "[date]: yep it's approved" as if the regulator just gives a meaningless rubber stamp to whatever the drug company says, and not a whole load of detailed rules and guidelines about how [and how not] to produce, transport, store, and administer the vaccine. Please explain this to us, because nobody else seems to be doing it.)
tom p wrote: ↑Fri Mar 19, 2021 9:19 am
The stopping had nothing to do with the EMA or the science of the thing & was 100% national politicians choosing to temporarily pause it because others had (once the first one panicked, the others were bound to - who wants to be the last one to stop giving the killer drug?)
Well, it wasn't the EMA but it was each nation's equivalent regulator which made the decision. In Italy's case it's the AIFA. I don't remember politicians here ever saying anything other than it was safe but let's check to be sure. France is a bit of a different matter, maybe.
tom p wrote: ↑Fri Mar 19, 2021 9:19 am
The [EMA|
https://www.ema.europa.eu/en] have actually published [very detailed but clear (at least to me) documents|
https://www.ema.europa.eu/en/news/covid ... lood-clots] and did a press conference and stuff (Emer Cooke, head of the EMA, was broadcast on the BBC news at 6) to give as much detail as clearly as possible. I think they did as good a job as possible in the circumstances.
Ultimately, the extremely rare DIC & CSVT are probably not related, but it is not presently possible to exclude this possibility and so a warning has been added to the labelling.
Thanks for the link. Of course I didn't see the BBC news.
I think the MHRA will need to be vigilant once the UK's mass vaccination campaign reaches the 40-50 age range. I look forward to moron UK journalists pouncing on rare adverse effects in younger* people.